ABEL
DEAD

Serial Number

90132893

Owner

Knight Scientific Limited

Attorney

Nicholas D. Wells

Filing Date

Aug 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ABEL Trademark

Serial Number: 90132893

ABEL is a trademark filed by Knight Scientific Limited on August 24, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Knight Scientific Limited (2 trademarks)

15 Wolseley Close Business Park
Plymouth, Devon PL23BY , GB

Entity Type: 99

Trademark Details

Filing Date

August 24, 2020

Registration Date

Not Registered

Goods & Services

Apparatus and instruments, namely, research laboratory analyzers for analyzing or testing of blood or other bodily fluids using light, not for medical or veterinary purposes; downloadable computer software for use in analyzing data from testing blood or other bodily fluids using light, research laboratory equipment, devices and instruments, namely, analyzers for testing blood or other bodily fluids using light

Medical or veterinary diagnostic reagents and assays for testing of blood or other bodily fluids using light; immunoassay reagents for medical or veterinary use; kits including any of the aforesaid goods, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sexually transmitted diseases, high white blood cell count, viral infections, bacterial infections, and also for quantifying the antioxidant activity of a mass of material against specific reactive oxygen species; reagents in kit form, namely, diagnostic kits comprised of medical diagnostic reagents and assays for medical or veterinary testing of blood or other bodily fluids using light for sexually transmitted diseases, high white blood cell count, viral infections, bacterial infections, and for quantifying the antioxidant activity of a mass of material against specific reactive oxygen species

Chemical preparations and substances for use in laboratory testing, analysis or diagnostic testing of blood or other bodily fluids using light, other than for medical or veterinary purposes; reagents for scientific or medical research of blood or other bodily fluids using light

Medical diagnostic testing, analysis or monitoring equipment, devices and instruments for medical or veterinary purposes for analyzing blood or other bodily fluids using light; Diagnostic kits consisting primarily of buffers and reagents for use in testing and analyzing blood or other bodily fluids using light, for medical or veterinary use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 31, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 31, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 7, 2025 XELR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Nov 7, 2024 GNS1
SUBSEQUENT FINAL EMAILED
Nov 7, 2024 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Nov 7, 2024 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2024 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 6, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 6, 2024 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2024 CRFA
ASSIGNED TO LIE
Feb 1, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 27, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 27, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 27, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 27, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 22, 2023 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 16, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 13, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 16, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 14, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 14, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 14, 2021 CNFR
DATA MODIFICATION COMPLETED
Nov 5, 2021 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2021 CRFA
ASSIGNED TO LIE
Oct 13, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 7, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jul 26, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2020 NWOS
NEW APPLICATION ENTERED
Aug 27, 2020 NWAP